Skip to content
Companies

Centile Bio

Brain imaging biomarkers from existing scan archives

Raised to date

$3.1M

of $4.1M offered across 1 Form D filing

Still open
$1M
Investors
3
Last filed
Apr 16, 2026

About

Centile Bio is a neuroimaging company that sells CentileOS, a platform that turns existing brain imaging archives into standardized, population-referenced biomarkers. It curates archived imaging data, extracts brain volumes and age-adjusted centile scores, and produces outputs for clinical decisions, trial endpoints and research. Customers are hospitals and health systems, and pharma and biotech companies. Its co-founders include authors of the Brain Charts for the Human Lifespan study.

It works from imaging archives hospitals already have, with no new hardware or protocols, and reports a reference dataset of over 1 million imaging studies from more than 200,000 people across the lifespan.

Funding

  • EquityFiled Apr 16, 2026Form D
    $3.1M/ $4.1M

Product

CentileOS

Neuroimaging analytics software

Curates existing brain imaging archives, quantifies brain volumes and structures as age-adjusted centile scores, and translates them into outputs for clinical care, trial endpoints and research.

  • Works on existing imaging archives with no new hardware or protocols
  • Brain volume and structure measurements
  • Age-adjusted centile scores against population references

Built for

Hospitals and health systems, and pharma and biotech companies

People on file